National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Chronic Lymphocytic Leukemia Treatment (PDQ®)     
Last Modified: 10/03/2008
Health Professional Version
Changes to This Summary (10/03/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Treatment Option Overview 1

Added Maddocks-Christianson et al. as reference 8 2.

Stage I, II, III, and IV Chronic Lymphocytic Leukemia 3

Added Dearden et al. as reference 21 4.

Added text 5 on alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia (cited Hillmen et al. as reference 34 and level of evidence 1iiDii).


Table of Links

1http://cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/30.cdr#Sect
ion_30
2http://cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/34.cdr#Sect
ion_34
3http://cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/56.cdr#Sect
ion_56
4http://cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/115.cdr#Sec
tion_115
5http://cancer.gov/cancertopics/pdq/treatment/CLL/healthprofessional/109.cdr#Sec
tion_109